Amgen, Inc. (AMGN)
384.32
+16.52
(+4.49%)
USD |
NASDAQ |
Feb 06, 16:00
382.63
-1.69
(-0.44%)
Pre-Market: 08:29
Amgen EPS Diluted (Quarterly) : 2.45 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| Merck & Co., Inc. | 1.191 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.333B |
| Revenue (Quarterly) | 9.866B |
| Total Expenses (Quarterly) | 8.533B |
| Enterprise Value | 252.62B |
| Gross Profit Margin (Quarterly) | 81.86% |
| Profit Margin (Quarterly) | 13.51% |
| Earnings Yield | 3.70% |
| Operating Earnings Yield | 4.92% |